Loading…

(2,2‘:6‘,2‘ ‘-Terpyridine)platinum(II) Complexes Are Irreversible Inhibitors of Trypanosoma c ruzi Trypanothione Reductase But Not of Human Glutathione Reductase

(2,2‘:6‘,2‘ ‘-Terpyridine)platinum(II) complexes possess pronounced cytostatic activities against trypanosomes and leishmania. As shown here, the complexes are irreversible inhibitors of trypanothione reductase (TR) from Trypanosoma cruzi, the causative agent of Chagas' disease. The most effect...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2000-12, Vol.43 (25), p.4812-4821
Main Authors: Bonse, Susanne, Richards, Jonathan M, Ross, Steven A, Lowe, Gordon, Krauth-Siegel, R. Luise
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:(2,2‘:6‘,2‘ ‘-Terpyridine)platinum(II) complexes possess pronounced cytostatic activities against trypanosomes and leishmania. As shown here, the complexes are irreversible inhibitors of trypanothione reductase (TR) from Trypanosoma cruzi, the causative agent of Chagas' disease. The most effective derivatives are the (4‘-chloro-2,2‘:6‘,2‘ ‘-terpyridine)platinum(II) ammine and the (4-picoline)(4‘-p-bromophenyl-2,2‘:6‘,2‘ ‘-terpyridine)platinum(II) complexes which in the presence of NADPH inhibit TR with second-order rate constants of about 1.3 × 104 M-1 s-1. The modified enzyme species possess increased oxidase activities. The inhibition is not reversed upon dialysis or treatment with low-molecular-mass thiols. Kinetic and spectroscopic data suggest that Cys52 in the active site has been specifically altered. Inhibition of this key enzyme of parasite thiol metabolism probably contributes to the antitrypanosomal activity of the compounds. In contrast to the parasite enzyme, most (terpyridine)platinum complexes interact only reversibly with human glutathione reductase and an initial inhibition is completely abolished during the course of the assay.
ISSN:0022-2623
1520-4804
DOI:10.1021/jm000219o